4//SEC Filing
MAY MICHAEL H 4
Accession 0001209191-21-042894
CIK 0001708599other
Filed
Jun 22, 8:00 PM ET
Accepted
Jun 23, 9:46 PM ET
Size
7.6 KB
Accession
0001209191-21-042894
Insider Transaction Report
Form 4
MAY MICHAEL H
Director
Transactions
- Award
Option to Purchase Common Stock
2021-06-21+35,000→ 35,000 totalExercise: $1.48From: 2021-06-21Exp: 2031-06-20→ Common Stock (35,000 underlying) - Award
Option to Purchase Common Stock
2021-06-21+65,000→ 65,000 totalExercise: $1.48Exp: 2031-06-20→ Common Stock (65,000 underlying)
Footnotes (1)
- [F1]Options will vest and become exercisable in four equal quarterly installments on June 30, 2021, September 30, 2021, December 31, 2021, and March 31, 2022, provided that the grantee remains a director on the last day of the applicable calendar quarter.
Documents
Issuer
AgeX Therapeutics, Inc.
CIK 0001708599
Entity typeother
Related Parties
1- filerCIK 0001785908
Filing Metadata
- Form type
- 4
- Filed
- Jun 22, 8:00 PM ET
- Accepted
- Jun 23, 9:46 PM ET
- Size
- 7.6 KB